[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608385":3},{"organization":4,"outcomesModule":7,"designInfo":19,"detailedDescription":22,"studyPopulation":23,"armGroups":24,"interventions":30,"overallOfficials":18,"centralContacts":35,"locations":44,"responsibleParty":55,"collaborators":18,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":18,"studyType":72,"phases":18,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":82,"whyStopped":18,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Assiut University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":18},[9],{"measure":10,"description":11,"timeFrame":12},"Incidence of vaso-occlusive crisis in pediatric sickle cell patients","Frequency of vaso-occlusive crisis episodes will be identified through retrospective chart review of pediatric sickle cell patients.","Retrospective review of medical records from 2019 to 2024",[14],{"measure":15,"description":16,"timeFrame":17},"Complications associated with vaso-occlusive crisis (e.g., acute chest syndrome, stroke, infections)","Complications related to vaso-occlusive crisis will be identified and documented from patient records.","Throughout the study period (2019-2024)",null,{"allocation":18,"interventionModel":18,"interventionModelDescription":18,"primaryPurpose":18,"observationalModel":20,"timePerspective":21,"maskingInfo":18},"COHORT","RETROSPECTIVE","Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells, which leads to recurrent vaso-occlusive crises (VOC). These painful episodes are among the most common causes of hospitalization and are associated with significant morbidity in pediatric patients. Despite ongoing improvements in the management of sickle cell disease, there is still limited data describing the incidence, risk factors, and clinical outcomes of VOC in children within our population.\n\nThis study is designed to retrospectively analyze medical records of pediatric patients with sickle cell disease at Faculty of Medicine, Assiut University. The primary aim is to estimate the incidence of vaso-occlusive crises and to identify the most frequent complications. Secondary objectives include evaluating treatment approaches, length of hospital stay, and clinical outcomes. Findings from this study are expected to provide valuable insights that may help improve clinical care strategies and preventive measures for affected children.","Pediatric patients (1-18 years) with confirmed Sickle Cell Disease. The study observes the incidence and outcomes of vaso-occlusive crises (VOCs). Both sexes are eligible. Healthy volunteers are not included.",[25],{"label":26,"type":18,"description":27,"interventionNames":28},"Sickle Cell pediatric patients","Children with sickle cell disease whose medical records will be retrospectively reviewed at Assiut University Hospital.",[29],"Other: No intervention",[31],{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":18},"No intervention","retrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.",[26],[36,41],{"name":37,"role":38,"phone":39,"phoneExt":39,"email":40},"Nadia Fawzy, Pediatrician","CONTACT","+201552865958","Nadiafawzy730@gmail.com",{"name":42,"role":38,"phone":18,"phoneExt":18,"email":43},"Assiut University research office","pr.med@aun.edu.eg",[45],{"facility":5,"status":18,"city":46,"state":18,"zip":18,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":18},"Asyut","Egypt","EG",{"type":50,"coordinates":51},"Point",[52,53],31.18368,27.18096,{"lat":53,"lon":52},{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Nadia Fawzy Fahmy Hanna","Principle investigator","100608385","outcomes-of-vaso-occlusive-crisis-in-pediatric-sickle-cell-disease-100608385",false,"NCT07200869","Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease","Vaso-occlusive Crisis Incidence and Outcomes in a Pediatric Sickle Cell Population","Inclusion Criteria:\n\n* Children aged 1-18 years. Confirmed diagnosis of sickle cell anemia by hemoglobin electrophoresis or high-performance liquid chromatography .\n\nHistory of at least one hospital visit or admission for vaso-occlusive crisis\n\nExclusion Criteria:\n\n* Patients with other hemoglobinopathies (e.g., thalassemia). Patients with incomplete medical records. Children with coexisting chronic diseases that may confound pain crises .","ALL","1 Year","18 Years",{"count":70,"type":71},25,"ESTIMATED","OBSERVATIONAL","This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.",[75,76],"Sickle Cell Disease","Vaso-occlusive Crisis",[78,79,80,81],"Pediatric","Sickle Cell Anemia","Incidence","Outcomes","NOT_YET_RECRUITING","2025-09-23",{"date":85,"type":86},"2025-10-01","ACTUAL",{"date":88,"type":71},"2025-10",{"date":90,"type":71},"2027-11",{"name":5,"class":6},1]